You can write in Portuguese, English, Spanish or French. The search doesn't link to accents or uppercase letters, separates the words (all must appear) and also searches for the equivalent word in other languages: "transplant" finds "transplant" and "trasplante". Searches in the original titles, translated titles into Portuguese, descriptions and abstracts. MielomaAI.
In the last 3 months. From the older news, only the title and link remain in the archive. Those that have about 1 year may no longer be up to date
Looking for words: mieloma + latente. Saltar para: Recent news (1) · My Hematology (0) · explanations (2) · file (8)
What can our genes tell us about preventing myeloma?Cancer Research UK - Cancer News (Reino Unido) · 07:00 InvestigaçãoReino UnidoResearchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma.
Click on an article to open it on the side with the summary. MielomaAI And the link to the source.
- Smouldering myeloma
- Protein M of 3 g/dL or more, or 10% to 60% plasma cells in the bone marrow, but without CRAB signs. How to manage or treat: Close monitoring (every 3 or 6 months) with imaging tests. In high-risk latency, daratumumab may be administered or entry into a clinical trial may be considered. Risk: Approximately 10% per year during the first 5 years. High risk when 2 or 3 of the following are present: more than 20% plasma cells, protein M above 2 g/dL, light chain ratio above 20. See the film "Types of myeloma" →
- Latent
- Smoldering myeloma: protein M of 3 g/dL or higher, or 10% to 60% plasma cells in the bone marrow, but without organ damage. Approximately 10% per year evolve to active myeloma in the first 5 years.
Access and public health
- FDA approves first treatment for latent multiple myeloma ↗ about 1 year · Oncology News Central · 11/07/2025
- DARZALEX FASPRO® is the first and only treatment approved by the FDA in the US for high-risk latent multiple myeloma ↗ about 1 year · PR Newswire · 11/06/2025
- European Commission approves DARZALEX Faspro® for latent multiple myeloma in adults ↗ about 1 year · PR Newswire · 07/23/2025
Patients and associations
- Lauren Laverne diagnosed with indolent myeloma ↗ · Blood Cancer UK · 17/07/2026
- Smoldering myeloma ↗ about 1 year · Myeloma UK · 05/09/2025
- Study shows that new treatment may delay progression in high-risk latent multiple myeloma ↗ about 1 year · ScienceDaily — Multiple Myeloma · 10/12/2024
- Latent myeloma ↗ 2 years · Blood Cancer UK · 15/05/2024
Treatments
- Project information | Daratumumab for treating high-risk smouldering multiple myeloma [D10] | Guidance ↗ 2 years · NICE website · 10/04/2024
